Total assets decreased 11.0%
Total assets changed -11.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed -11.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed -9.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Current liabilities changed +10.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -14.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed -19.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +118 basis points from the comparable as-filed period.
Cost of revenue changed +41.2% from the comparable as-filed period.
Operating income changed +13.5% from the comparable as-filed period.
Operating cash-flow margin changed -607 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -620 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +67.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +10.2% from the comparable as-filed period.
Free-cash-flow proxy changed -3.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +12.7% from the comparable as-filed period.
Gross margin changed -88 basis points from the comparable as-filed period.
Operating cash flow changed -3.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +25.0% from the comparable as-filed period.
Research & development changed +5.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed -11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +13 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -152 basis points from the comparable as-filed period.
Operating cash flow / net income changed -14.4% from the comparable as-filed period.
Current assets changed -5.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
SBC / revenue changed -81 basis points from the comparable as-filed period.
Working capital / assets changed -23 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -5 basis points from the comparable as-filed period.
Inventory changed +9.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed -7.0% from the comparable as-filed period.
Cash & equivalents changed +71.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +552.0% from the comparable as-filed period.
Operating cash flow changed +528.1% from the comparable as-filed period.
Shares outstanding changed -8.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Operating margin changed +193 basis points from the comparable as-filed period.
Operating income changed +16.3% from the comparable as-filed period.
Current liabilities changed +7.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Capital expenditure changed +140.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow / net income changed +447.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +10.6% from the comparable as-filed period.
Total assets changed -6.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +3974 basis points from the comparable as-filed period.
Operating cash-flow margin changed +4033 basis points from the comparable as-filed period.
Net income changed +14.7% from the comparable as-filed period.
Working capital / assets changed +410 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +58 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +5.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +5.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +22.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +5.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -154 basis points from the comparable as-filed period.
SBC / revenue changed -117 basis points from the comparable as-filed period.
Selling, general & administrative changed +9.5% from the comparable as-filed period.
Inventory / revenue changed +44 basis points from the comparable as-filed period.
Stock-based compensation changed -9.7% from the comparable as-filed period.
Current ratio changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.